Baby Born Healthy in Brazil After Rare Intrauterine Treatment for Gestational Aloimmune Liver Disease

In an unprecedented medical achievement in Brazil, a baby named Bento Vasconcelos Dutra was born healthy in Uberaba after receiving treatment for a rare condition while still in the womb. At 14 weeks of gestation, Bento began receiving treatment for Gestational Aloimmune Liver Disease (GALD), a condition that can cause severe liver failure and be fatal to the fetus or newborn. The treatment involved weekly intravenous immunoglobulin infusions administered to his mother, Isabela Vasconcelos, a pediatrician. This intervention was crucial for the family, who had previously lost their daughter, Betina, to the same disease. GALD occurs when maternal antibodies cross the placenta and attack the fetus's liver, leading to severe damage and complications during pregnancy. The medical strategy aimed to prevent these maternal antibodies from continuing to harm Bento's developing liver. After months of careful monitoring by specialists in Uberaba and São Paulo, Bento was born healthy, a outcome his parents attribute to the early intrauterine treatment. The parents, Isabela and Raul Dutra, an oncologist, shared their experience to raise awareness about the importance of early diagnosis and treatment for GALD, a disease that often lacks prenatal diagnostic signs. Following Betina's death, they established the Instituto Betina to support vulnerable families and promote awareness of rare diseases in their region.